Zanaflex Capsule
Product Images NDC 70515-604

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Zanaflex (NDC 70515-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Covis Pharma Us, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

FDA Label Image

Figure 1 (Image 02)

FDA Label Image

Figure 2 (Image 03)

This appears to be a graph showing the improvement in Ashworth Score as a function of time post-dose for two different doses (8mg and 16mg) of tizanidine. The x-axis shows the hours post-dose, and the y-axis shows the Ashworth Score, which is a measure of spasticity in patients with neurological conditions. However, without knowing more about the context in which this graph appears, it is difficult to provide more information.*

FDA Label Image

Figure 3 (Image 04)

This text suggests that there was an improvement in Ashworth Score after taking Tizanidine. The mean dose was 26.8 mg. The rest of the text is not clear or readable.*

FDA Label Image

Principal Display Panel (2 mg Capsule Bottle)

Each capsule contains 229 mg of tizanidine hydrochloride, equivalent to 2mg of tizanidine base. Manufactured by Covis Pharma in Switzerland, Zanaflex Capsules ® comes in 150 capsules. It is recommended to store it at a temperature between 15-30°C or a USP Controlled Room Temperature, and to dispense in containers with child-resistant closure. Keep it out of the reach of children. No prescribing information provided.*

FDA Label Image

Principal Display Panel (4 mg Capsule Bottle)

Zanaflex is a medication that contains tizanidine hydrochloride. Each capsule has 4.58mg of tizanidine hydrochloride equivalent to 4 mg of tizanidine base. It is manufactured by CovisPharma and comes in a container of 150 capsules. The medication should be stored at room temperature and out of reach of children. Prescribing information can be found in the package insert. The product has a GTIN number of 0037051560415.*

FDA Label Image

Principal Display Panel (6 mg Capsule Bottle)

Each capsule contains 6.87 mg tizanidine hydrochloride, equivalent to mg tizanidine base. Manufactured by Covis Pharma in Zug, Switzerland. Zanaflex Capsules come in a 150 count bottle and include prescribing information in the package insert. Store at room temperature and keep in containers with child-resistant closures. The lot number and expiration date are printed on the packaging. Keep out of reach of children.*

FDA Label Image

Principal Display Panel (4 mg Tablet Bottle)

This is a description of a medication called Tizanidine Hydrochloride, which comes in tablet form. Each tablet contains 4576 grams of tizanidine HCI (tizanidine base). The medication is packaged in a bottle of 150 tablets and has an NDC number of 70515. There isn't any information on what the medication is used for or any dosage instructions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.